| Scott Allen Dyer, DO | |
|
35 Medical Center Pkwy, Augusta, ME 04330-8160 | |
| (207) 622-8660 | |
| (207) 622-8661 |
| Full Name | Scott Allen Dyer |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 23 Years |
| Location | 35 Medical Center Pkwy, Augusta, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508807751 | NPI | - | NPPES |
| 1508807751 | Medicaid | ME |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maine General Medical Center | Augusta, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainegeneral Medical Center | 1254245715 | 487 |
News Archive
The prevalence of smoking in Christchurch, New Zealand, increased following the 2010 earthquake, according to a new study.
A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
A strain of the superbug MRSA (Methicillin-resistant Staphylococcus Aureus) is causing concern across the U.S. because it is becoming more common in the wider community.
› Verified 7 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
The prevalence of smoking in Christchurch, New Zealand, increased following the 2010 earthquake, according to a new study.
A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
A strain of the superbug MRSA (Methicillin-resistant Staphylococcus Aureus) is causing concern across the U.S. because it is becoming more common in the wider community.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Allen Dyer, DO 35 Medical Center Pkwy, Augusta, ME 04330-8160 Ph: (207) 622-8660 | Scott Allen Dyer, DO 35 Medical Center Pkwy, Augusta, ME 04330-8160 Ph: (207) 622-8660 |
News Archive
The prevalence of smoking in Christchurch, New Zealand, increased following the 2010 earthquake, according to a new study.
A team of researchers from the Netherlands demonstrated that prophylactic treatment with a high dose of human convalescent plasma or by using concentrated monoclonal antibodies could protect against disease following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in an animal model. However, no protective effect was observed with a ten-fold lower dose of convalescent plasma. The results are currently available on the bioRxiv* preprint server.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).
A strain of the superbug MRSA (Methicillin-resistant Staphylococcus Aureus) is causing concern across the U.S. because it is becoming more common in the wider community.
› Verified 7 days ago